Suppr超能文献

范可尼贫血蛋白A(Fanca)基因敲除、范可尼贫血蛋白C(Fancc)基因敲除和范可尼贫血蛋白D2(Fancd2)基因敲除小鼠造血祖细胞中CXC趋化因子受体4(CXCR4)的诱导情况

CXCR4 induction in hematopoietic progenitor cells from Fanca(-/-), -c(-/-), and -d2(-/-) mice.

作者信息

Skinner Amy M, O'Neill S Lee, Grompe Markus, Kurre Peter

机构信息

Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

Exp Hematol. 2008 Mar;36(3):273-82. doi: 10.1016/j.exphem.2007.11.006.

Abstract

OBJECTIVE

Bone marrow failure is a near-universal occurrence in patients with Fanconi anemia (FA) and is thought to result from exhaustion of the hematopoietic stem cell (HSC) pool. Retrovirus-mediated expression of the deficient protein corrects this phenotype and makes FA a candidate disease for HSC-directed gene therapy. However, inherent repopulation deficits and stem cell attrition during conventional transduction culture prevent therapeutic chimerism.

MATERIALS AND METHODS

We previously reported rapid transduction protocols to limit stem cell losses after ex vivo culture. Here we describe a complementary strategy intended to improve repopulation through upregulation of chemokine receptor (CXCR) 4, a principal factor in hematopoietic homing.

RESULTS

Using murine models with transgenic disruption of Fanca, -c, and -d2, we found that c-kit(+) and sca-1(+) progenitor cells express levels of CXCR4 comparable with those of wild-type littermates. Lineage-depleted progenitor populations rapidly upregulated CXCR4 transcript and protein in response to cytokine stimulation or hypoxia, regardless of genotype. Hypoxia conditioning of lineage-depleted Fancc(-/-) progenitors also reduced oxidative stress, improved in vitro migration and led to improved chimerism in myeloablated recipients after transplantation.

CONCLUSION

These studies provide evidence that CXCR4 regulation in progenitor cells from transgenic mice representing multiple FA genotypes is intact and that modulation of homing offers a potential strategy to offset the FA HSC repopulation deficiency.

摘要

目的

骨髓衰竭在范可尼贫血(FA)患者中几乎普遍存在,被认为是造血干细胞(HSC)池耗竭所致。逆转录病毒介导的缺陷蛋白表达可纠正此表型,使FA成为HSC定向基因治疗的候选疾病。然而,传统转导培养过程中固有的再增殖缺陷和干细胞损耗阻碍了治疗性嵌合体的形成。

材料与方法

我们之前报道了快速转导方案,以限制体外培养后的干细胞损失。在此,我们描述一种互补策略,旨在通过上调趋化因子受体(CXCR)4(造血归巢的主要因子)来改善再增殖。

结果

利用Fanca、-c和-d2基因被转基因破坏的小鼠模型,我们发现c-kit(+)和sca-1(+)祖细胞表达的CXCR4水平与野生型同窝仔相当。无论基因型如何,谱系清除的祖细胞群体在细胞因子刺激或缺氧反应中会迅速上调CXCR4转录本和蛋白。对谱系清除的Fancc(-/-)祖细胞进行缺氧预处理还可降低氧化应激,改善体外迁移,并在移植后提高清髓受体中的嵌合率。

结论

这些研究提供了证据,表明代表多种FA基因型的转基因小鼠祖细胞中的CXCR4调节是完整的,并且归巢调节为弥补FA HSC再增殖缺陷提供了一种潜在策略。

相似文献

1
CXCR4 induction in hematopoietic progenitor cells from Fanca(-/-), -c(-/-), and -d2(-/-) mice.
Exp Hematol. 2008 Mar;36(3):273-82. doi: 10.1016/j.exphem.2007.11.006.
5
Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
Stem Cell Reports. 2018 Feb 13;10(2):339-346. doi: 10.1016/j.stemcr.2017.12.006. Epub 2018 Jan 4.
6
Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.
Blood. 2008 Dec 1;112(12):4458-65. doi: 10.1182/blood-2007-07-102947. Epub 2008 Aug 6.
8
Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.
J Clin Invest. 2020 Mar 2;130(3):1377-1391. doi: 10.1172/JCI131540.

引用本文的文献

1
Leukemic Stem Cells and Hematological Malignancies.
Int J Mol Sci. 2024 Jun 17;25(12):6639. doi: 10.3390/ijms25126639.
2
Consequences of HIV infection in the bone marrow niche.
Front Immunol. 2023 Jul 11;14:1163012. doi: 10.3389/fimmu.2023.1163012. eCollection 2023.
3
Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2 Hematopoietic Stem and Progenitor Cells.
Stem Cell Reports. 2016 Nov 8;7(5):840-853. doi: 10.1016/j.stemcr.2016.09.005. Epub 2016 Oct 6.
4
Mammalian CNTD1 is critical for meiotic crossover maturation and deselection of excess precrossover sites.
J Cell Biol. 2014 Jun 9;205(5):633-41. doi: 10.1083/jcb.201401122. Epub 2014 Jun 2.
5
Fetal origins of hematopoietic failure in a murine model of Fanconi anemia.
Blood. 2013 Mar 14;121(11):2008-12. doi: 10.1182/blood-2012-06-439679. Epub 2013 Jan 11.
8
Is hematopoietic stem cell homing deficient in Fanconi anemia?
Blood. 2009 May 21;113(21):5361; author reply 5362. doi: 10.1182/blood-2008-12-192724.
9
Mouse models of Fanconi anemia.
Mutat Res. 2009 Jul 31;668(1-2):133-40. doi: 10.1016/j.mrfmmm.2009.03.015. Epub 2009 Apr 10.

本文引用的文献

1
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche.
Blood. 2007 Oct 15;110(8):3056-63. doi: 10.1182/blood-2007-05-087759. Epub 2007 Jun 26.
2
Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.
J Immunol. 2007 Apr 15;178(8):5277-87. doi: 10.4049/jimmunol.178.8.5277.
3
Stem cell collection and gene transfer in Fanconi anemia.
Mol Ther. 2007 Jan;15(1):211-9. doi: 10.1038/sj.mt.6300033.
4
Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1.
Mol Ther. 2006 Oct;14(4):525-35. doi: 10.1016/j.ymthe.2006.05.018. Epub 2006 Jul 20.
5
Fanconi anemia.
Semin Hematol. 2006 Jul;43(3):147-56. doi: 10.1053/j.seminhematol.2006.04.005.
6
Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.
Exp Hematol. 2006 Apr;34(4):433-42. doi: 10.1016/j.exphem.2005.12.014.
7
Molecular pathogenesis of Fanconi anemia: recent progress.
Blood. 2006 Jun 1;107(11):4223-33. doi: 10.1182/blood-2005-10-4240. Epub 2006 Feb 21.
8
In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2340-5. doi: 10.1073/pnas.0510613103. Epub 2006 Feb 6.
9
Hemopoietic stem cell engraftment.
Exp Hematol. 2006 Feb;34(2):123-9. doi: 10.1016/j.exphem.2005.08.006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验